Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sc ...
PROmyBETAapp: Ascertaining Medication Usage & Documentation of Patient Reported Outcomes Utilizing the myBETAapp® in Patients With Multiple Sclerosis Treated With Betaferon®: a Pilot Study PROmyBETAapp: Ascertaining Medication Usage & Documentation of Patient Reported Outcomes Utilizing t ...
BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon BETAEVAL Global - The New BETACONNECT Auto-injector: Adherence and EVALuation of Multiple Sclerosis ...
BETAEVAL_Global- The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon® BETAEVAL_Global- The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated ...
Multiple Sclerosis, Relapsing Remitting
Drug: Interferon beta-1b (Betaferon®, BAY 86-5046);Device: BETACONNECT
Bayer
NULL
Completed
N/A
N/A
All
498
N/A
Austria;Belgium;Bosnia and Herzegovina;Croatia;Czechia;France;Greece;Hungary;Italy;Spain;Switzerland;Czech Republic;Netherlands Austria;Belgium;Bosnia and Herzegovina;Croatia;Czechia;France;Greece;Hungary;Italy;Spain;Switzerland ...
BAY86-5046 (Betaseron), Non Interventional Studies
BETAEVAL - The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon® BETAEVAL - The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With ...
Multiple Sclerosis
Drug: Interferon beta-1b (Betaferon, BAY 86-5046);Device: BETACONNECT auto-injector.